The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »
The whole world is waiting with great anticipation for a ‘safe and effective’ vaccine against the new coronavirus. The central government expects a COVID-19 vaccine to be ready for sale in India from December if clinical trials are successful, according to mint report. Currently, three candidate vaccines are in different …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »
Written by Abhishek De | New Delhi | Updated: September 7, 2020 9:27:45 pm According to the World Health Organization, about 175 vaccine candidates are in preclinical or clinical trials today. While Russia and China may have stolen a march in the race to develop a Covid-19 vaccine, grant regulatory …
Read More »